Cargando…

Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice

BACKGROUND: Despite clear evidence for the effectiveness of oral anticoagulation (OA) in patients with atrial fibrillation (AF), there is evidence for the underutilisation of this therapy in the secondary stroke prevention. We therefore investigate the link between the use of OA in stroke patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanislav, Christian, Milde, Sonja, Schwartzkopff, Sabine, Sieweke, Nicole, Krämer, Heidrun Helga, Juenemann, Martin, Misselwitz, Björn, Kaps, Manfred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189749/ https://www.ncbi.nlm.nih.gov/pubmed/25265943 http://dx.doi.org/10.1186/s12883-014-0195-y

Ejemplares similares

Baseline characteristics in stroke patients with atrial fibrillation: clinical trials versus clinical practice
por: Tanislav, Christian, et al.
Publicado: (2015)

Cardiac Troponin I elevation after epileptic seizure
por: Sieweke, Nicole, et al.
Publicado: (2012)

Factors associated with shunt dynamic in patients with cryptogenic stroke and patent foramen ovale: an observational cohort study
por: Tanislav, Christian, et al.
Publicado: (2011)

Cerebral vein thrombosis: clinical manifestation and diagnosis
por: Tanislav, Christian, et al.
Publicado: (2011)

Adjustment of oral diet based on flexible endoscopic evaluation of swallowing (FEES) in acute stroke patients: a cross-sectional hospital-based registry study
por: Braun, Tobias, et al.
Publicado: (2019)

What is the value of fibre-endoscopic evaluation of swallowing (FEES) in neurological patients? A cross-sectional hospital-based registry study
por: Braun, Tobias, et al.
Publicado: (2018)

Neuromuscular sonography detects changes in muscle echotexture and nerve diameter in ICU patients within 24 h
por: Bulinski, Catherine, et al.
Publicado: (2021)

Lessons from everyday stroke care for clinical research and vice versa: comparison of a comprehensive and a research population of young stroke patients
por: Tanislav, Christian, et al.
Publicado: (2014)

Atrial fibrillation and silent stroke: links, risks, and challenges
por: Hahne, Kathrin, et al.
Publicado: (2016)

National Institutes of Health Stroke Scale (NIHSS) on admission predicts acute symptomatic seizure risk in ischemic stroke: a population-based study involving 135,117 cases
por: Zöllner, Johann Philipp, et al.
Publicado: (2020)

Erratum to: NOACs for secondary stroke prevention in patients with atrial fibrillation
Publicado: (2020)

Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale
por: Tanislav, Christian, et al.
Publicado: (2010)

Septal total atrial conduction time for prediction of atrial fibrillation in embolic stroke of unknown source: a pilot study
por: Sieweke, Jan-Thorben, et al.
Publicado: (2019)

Markers of endothelial pathology to support detection of atrial fibrillation in embolic stroke of undetermined source
por: Ziegler, Nora L., et al.
Publicado: (2019)

Clinical signs in young patients with stroke related to FAST: results of the sifap1 study
por: Kaps, Manfred, et al.
Publicado: (2014)

High prevalence of atrial fibrillation among Greenlanders with ischemic stroke – atrial fibrillation found in more than 30% of cases
por: Bjorn-Mortensen, Karen, et al.
Publicado: (2013)

Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
por: Mahnkopf, Christian, et al.
Publicado: (2021)

Atrial Fibrillation Related and Unrelated Stroke Recurrence Among Ischemic Stroke Patients With Atrial Fibrillation
por: Kim, Bum Joon, et al.
Publicado: (2021)

Neuroprotective mechanisms of erythropoietin in a rat stroke model
por: Juenemann, Martin, et al.
Publicado: (2020)

Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review
por: Alcocer, Luis
Publicado: (2016)

Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation?
por: Lin, Yi-Pin, et al.
Publicado: (2015)

Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Plasma Dimethylarginine Levels and Carotid Intima–Media Thickness are related to Atrial Fibrillation in Patients with Embolic Stroke
por: Grosse, Gerrit M., et al.
Publicado: (2019)

Quality assurance data for regional drip-and-ship strategies- gearing up the transfer process
por: Boss, Erendira G., et al.
Publicado: (2021)

Paroxysmal atrial fibrillation in cryptogenic stroke
por: Dangayach, Neha S, et al.
Publicado: (2011)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

Stroke as the First Manifestation of Atrial Fibrillation
por: Jaakkola, Jussi, et al.
Publicado: (2016)

Stroke Prevention in Patients with Atrial Fibrillation
por: Kowey, Peter R.
Publicado: (2018)

Residual Stroke Risk in Atrial Fibrillation
por: Ding, Wern Yew
Publicado: (2021)

Percutaneous closure of the left atrial appendage for secondary prevention of stroke in patients with atrial fibrillation and contraindications to chronic anticoagulant therapy
por: Lasek-Bal, Anetta, et al.
Publicado: (2015)

Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction
por: Edwards, Jodi D., et al.
Publicado: (2020)

Dabigatran for Stroke Prevention in Nonvalvular Atrial Fibrillation: Answers to Challenging “Real-World” Questions
por: Ferreira, Jorge, et al.
Publicado: (2012)

Stroke in a Young Man Secondary to Paroxysmal Atrial Fibrillation and Thyrotoxicosis: A Case Report
por: Bazan, Rodrigo, et al.
Publicado: (2017)

The impact of competing stroke etiologies in patients with atrial fibrillation
por: Zietz, Annaelle, et al.
Publicado: (2023)

Secondary Prevention of Atrial Fibrillation: Is It Worth Doing?
por: De Vecchis, Renato
Publicado: (2019)

How to Manage Atrial Fibrillation Secondary to Ibrutinib
por: Essa, Hani, et al.
Publicado: (2021)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation
por: Patel, Taral K., et al.
Publicado: (2012)

The atrial fibrillation paradox -connecting hypertension to atrial disease and stroke
por: Mendys, Phil, et al.
Publicado: (2021)

Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
por: Ratajczak-Tretel, B, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_936qmhb1cg6cjqujp2vbpigeks